Capital Goods · NSE: ELECTCAST
Electrosteel Castings
Q2 FY27 earnings highlights, from the results presentation
Q2 FY27 · From the investor presentation
- M.Cap
- ₹4,194Cr
- P/E
- 45.0×
- 1Y return
- −15.86%
- From 52W high
- −29.3%
Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.
Share price
Results Q2 FY27, as filed · consolidated · ₹ Cr
| Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ | |
|---|---|---|---|---|---|
| Revenue | 1,520 | 1,396 | +8.9% | 1,426 | +6.6% |
| EBITDA | 100 | 93 | +8.2% | 100 | +0.4% |
| EBITDA margin | 6.6% | 6.7% | -4 bps | 7.0% | -40 bps |
| PBTProfit before tax | 65 | 107 | -39.4% | 69 | -5.6% |
| Net profit | 51 | 78 | -35.2% | 48 | +5.0% |
| EPS (₹) | 0.82 | 1.27 | -35.4% | 0.78 | +5.1% |
From the company's own results filing on NSE. Net profit is the owners' share. Growth and the dotted lines are worked out from the filed figures.
Guidance
More figures from the presentation
“• Phase 1: Expected to have 1,000 KL p.a. capacity by March 2027 & 4,000 KL p.a. by September 2027”
“Existing 4,200 KL facility with phased capacity expansion and broadened coating portfolio”
“• Manufacturing Capacity: Production capacity of approx. 1 Mn TPA across DI pipes, DI fittings and CI pipes”
“• DI Pipe capacity: 9,00,000 MT | DI Fittings: 21,000”
“4,200 KL Captive Consumption in Foraying in Industrial 17,000 KL”
“• Focused Entry Strategy: Initially target ₹7,000-9,000 crore protective coating segments aligned with existing capabilities”
In short
- 01Q2 FY27 revenue from operations was Rs 1,520 crore; EBITDA Rs 139 crore at 8.9% margin.
- 02H1 FY27 PAT was Rs 99 crore versus Rs 167 crore in H1 FY26.
- 03Valves business targets about Rs 800 crore revenue by FY30-31 at about 16% EBITDA margin.
- 04Industrial paints target Rs 800-1,000 crore revenue over 5 years, with Rs 250-300 crore capex planned.
- 05Paints capacity of 1,000 KL p.a. expected by March 2027 and 4,000 KL p.a. by September 2027.
- 06Management expects a significant increase in JJM fund releases from the beginning of H2 FY27.
- 07FY25-26 demand was subdued due to slowdown of JJM funds release.
- 08Exports targeted at 25% of sales.
Capex
Valves: Valves production in India planned to start by March
Slides · p. 8
Valves: Valves production in India planned to start by March
“• Manufacturing in India: To start production in India by March”
Capacity
Valves: T.I.S. has two plants, in Italy and Turkey, with spare capacity
Slides · p. 8
Valves: T.I.S. has two plants, in Italy and Turkey, with spare capacity
“Two plants (Italy & Turkey, with spare capacity);”
Segments
Demand
Industrial Paints: Industrial paints market Rs 29,000 crore, growing about 10% CAGR, margins 14%-16%
Slides · p. 9
Industrial Paints: Industrial paints market Rs 29,000 crore, growing about 10% CAGR, margins 14%-16%
“• Market Opportunity: ₹29,000 crore market growing at ~10% CAGR with ~ EBITDA margins of approx. 14%-16%”
Significant increase in JJM fund releases expected
Slides · p. 11
Significant increase in JJM fund releases expected
“• Outlook: Significant increase in fund releases expected from the”
JJM 2.0 total outlay Rs 8.69 lakh crore, enhanced from Rs 3.60 lakh crore
₹8,69,000CrSlides · p. 11
JJM 2.0 total outlay Rs 8.69 lakh crore, enhanced from Rs 3.60 lakh crore
₹8,69,000Cr“• Total Outlay: ₹8.69 Lakh Crores (enhanced from ₹3.60 Lakh”
Central JJM funds sanctioned to states in FY27 so far: Rs 16,487 crore
Slides · p. 11
Central JJM funds sanctioned to states in FY27 so far: Rs 16,487 crore
“• Central funds sanctioned to states in FY27 (YTD): ₹16,487”
JJM release in FY25-26 was Rs 1,562 crore
Slides · p. 11
JJM release in FY25-26 was Rs 1,562 crore
“• Release in FY25 - 26: ₹1,562 crore”
Margins and costs
Q2 FY27 EBITDA at Rs 139 crore, EBITDA margin 8.9%
Slides · p. 14
Q2 FY27 EBITDA at Rs 139 crore, EBITDA margin 8.9%
“▪ EBITDA stood at ₹ 139 Crores in Q2FY27, EBITDA margin was at 8.9% during the quarter.”
Gross profit margin 47.3% in Q2 FY27 vs 49.0% a year ago
Slides · p. 14
Gross profit margin 47.3% in Q2 FY27 vs 49.0% a year ago
“Gross Profit margin 47.3% 48.9% (157bps) 49.0% (164bps) 48.1% 50.2% (212bps) 46.3%”
H1 FY27 EBITDA Rs 278 crore vs Rs 386 crore in H1 FY26
Slides · p. 14
H1 FY27 EBITDA Rs 278 crore vs Rs 386 crore in H1 FY26
“EBITDA* 139 139 (0.3%) 188 (26.1%) 278 386 (28.0%) 574”
Debt and working capital
Finance cost Rs 31 crore in Q2 FY27 vs Rs 38 crore a year ago
Slides · p. 14
Finance cost Rs 31 crore in Q2 FY27 vs Rs 38 crore a year ago
“Finance Cost 31 27 12.2% 38 (20.3%) 58 75 (22.7%) 144”
Current borrowings Rs 1,408 crore at 30 Sep 2026 vs Rs 1,259 crore at 31 Mar 2026
Slides · p. 15
Current borrowings Rs 1,408 crore at 30 Sep 2026 vs Rs 1,259 crore at 31 Mar 2026
“Borrowings 1,408 1,259”
Inventories Rs 2,494 crore at 30 Sep 2026 vs Rs 2,398 crore at 31 Mar 2026
Slides · p. 15
Inventories Rs 2,494 crore at 30 Sep 2026 vs Rs 2,398 crore at 31 Mar 2026
“Inventories 2,494 2,398”
Non-current borrowings Rs 217 crore at 30 Sep 2026 vs Rs 254 crore at 31 Mar 2026
Slides · p. 15
Non-current borrowings Rs 217 crore at 30 Sep 2026 vs Rs 254 crore at 31 Mar 2026
“Borrowings 217 254”
Total equity Rs 5,964 crore at 30 Sep 2026 vs Rs 5,924 crore at 31 Mar 2026
Slides · p. 15
Total equity Rs 5,964 crore at 30 Sep 2026 vs Rs 5,924 crore at 31 Mar 2026
“Total Equity 5,964 5,924”
Acquisitions and new business
Valves: T.I.S. Services (Italy) acquired in 2025 for about EUR 11.5 million from internal funds
Slides · p. 8
Valves: T.I.S. Services (Italy) acquired in 2025 for about EUR 11.5 million from internal funds
“Acquired 2025 for ~€11.5 million - funded from internal”
Valves: T.I.S. acquired at 7-8x EV/EBITDA; EV 31 million
Slides · p. 8
Valves: T.I.S. acquired at 7-8x EV/EBITDA; EV 31 million
“Valuation Acquired at 7-8x EV/EBITDA ; EV 31Mn”
Valves: T.I.S. turnover about EUR 41 million in CY25
Slides · p. 8
Valves: T.I.S. turnover about EUR 41 million in CY25
“Turnover ~€41 million in CY25”
Valves: Patented FR line product planned to grow the valves segment
Slides · p. 8
Valves: Patented FR line product planned to grow the valves segment
“• New Product Development: A patented FR line product to amplify”
Dividends and buybacks
Dividend of 90% to 140% of face value paid consistently
Slides · p. 2
Dividend of 90% to 140% of face value paid consistently
“90% - 140% of Face Value”
Risks
FY25-26 demand hit by slowdown of JJM funds release
Slides · p. 16
FY25-26 demand hit by slowdown of JJM funds release
“demand due to slowdown of JJM funds release in FY25-26 resulting”
DI Pipes: Low DI pipe sales owing to slowdown in JJM orders
Slides · p. 18
DI Pipes: Low DI pipe sales owing to slowdown in JJM orders
“normalized JJM rollout (Owing to slowdown in JJM orders) Migration to piped irrigation in India”
Other
Q2 FY27 revenue from operations at Rs 1,520 crore
Slides · p. 14
Q2 FY27 revenue from operations at Rs 1,520 crore
“▪ Revenue from Operations for Q2FY27 stood at ₹ 1,520 Crores.”
PAT Rs 51 crore in Q2 FY27 vs Rs 78 crore a year ago; H1 FY27 PAT Rs 99 crore vs Rs 167 crore
Slides · p. 14
PAT Rs 51 crore in Q2 FY27 vs Rs 78 crore a year ago; H1 FY27 PAT Rs 99 crore vs Rs 167 crore
“PAT 51 48 5.1% 78 (35.1%) 99 167 (40.7%) 161”
Other income Rs 38 crore in Q2 FY27 vs Rs 95 crore a year ago
Slides · p. 14
Other income Rs 38 crore in Q2 FY27 vs Rs 95 crore a year ago
“Other Income 38 39 (2.1%) 95 (59.6%) 78 123 (36.9%) 215”
Promoter stake rose to 54.53% in Q2 FY27 from 50.14% in Q1 FY27
Slides · p. 4
Promoter stake rose to 54.53% in Q2 FY27 from 50.14% in Q1 FY27
“• Rising Promoter's Stake: Promoter’s stake increased to 54.53% in Q2FY27 from 50.14% in Q1FY27”
H1 FY27 revenue from operations Rs 2,945 crore vs Rs 2,953 crore in H1 FY26
Slides · p. 14
H1 FY27 revenue from operations Rs 2,945 crore vs Rs 2,953 crore in H1 FY26
“Revenue from Operations 1,520 1,426 6.6% 1,396 8.9% 2,945 2,953 (0.3%) 5,918”
Sources
- Investor presentation, Q2 FY27 Filed 13 Nov 2026 · 21 pages
Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

